← Back to Patent Explorer
US5217866A Expired / Lapsed US ⏱️ 0.0 years remaining

Polynucleotide assay reagent and method

Assignee: NEU-GENE DEVELOPMENT
•
Filing: 1986-12-18
•
Granted: 1993-06-08
•
Expires: 2006-12-18
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A diagnostic reagent and system for determination of a single-stranded polynucleotide analyte having a selected target sequence. The reagent includes a solid support and multiple support-bound polymers designed to bind specifically to the analyte. Each polymer is composed of a sequence of base-complementary recognition moieties which can bind specifically to corresponding contiguous bases in the analyte target sequence, and an unbranched, substantially uncharged, substantially stereoregular backbone. A reporter in the system contains (a) a polycationic tail effective to bind electrostatically to the analyte, under conditions in which the reporter does not bind to the substantially uncharged polymers, and (b) reporter groups by which the presence of the reporter can be detected.

Inventors

  • 👤 James Summerton
  • 👤 Dwight Weller

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 15:49
CPC Classifications
C; C07; C07H; C07H21/00; A; A61; A61K; A61K47/00; A61K47/50; A61K47/51; A61K47/54; A61K47/545; A61K47/549; A61K47/56; A61K47/59; C07K; C07K14/00; C07K14/001; C07K14/003; C12; C12Q; C12Q1/00; C12Q1/68; C12Q1/6813; C12Q1/6816; C12Q1/682; B; B01; B01J; B01J2219/00; B01J2219/00274; B01J2219/00718; B01J2219/0072

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 188 words
A diagnostic system for determination of a single-stranded polynucleotide analyte containing a selected heteromeric target sequence of bases, said system comprising: a diagnostic reagent composed of a solid support, and attached to the solid support, multiple polymer molecules, each composed of a heteromeric sequence of base-complementary recognition moieties selected from the group consisting of purine and pyrimidine heterocycles adapted to hydrogen-bond to corresponding, contiguous bases in the target sequence, under selected binding conditions, and an unbranched, substantially uncharged backbone, composed of subunit backbone moieties, supporting the recognition moieties at positions which allow hydrogen bonding between the recognition moieties and the corresponding bases in the target sequence, where the subunit backbone moieties are chosen from a group consisting of cyclic moieties, of 5 to 7 atoms in length, and acyclic moieties, of 4 to 6 atoms in length; and, molecules of a reporter, where said reporter is composed of an oligocationic tail adapted to bind electrostatically to the charged backbone of the polynucleotide analyte, and attached to the tail, one or more reporter groups adapted to produce a signal by which the presence of the reporter can be detected.
Claim 2
Dependent Claim 188 words
A diagnostic system for determination of a single-stranded polynucleotide analyte containing a selected heteromeric target sequence of bases, said system comprising: a diagnostic reagent composed of a solid support, and attached to the solid support, multiple polymer molecules, each composed of a heteromeric sequence of base-complementary recognition moieties selected from the group consisting of purine and pyrimidine heterocycles adapted to hydrogen-bond to corresponding, contiguous bases in the target sequence, under selected binding conditions, and an unbranched, substantially uncharged backbone, composed of subunit backbone moieties, supporting the recognition moieties at positions which allow hydrogen bonding between the recognition moieties and the corresponding bases in the target sequence, where the subunit backbone moieties are chosen from a group consisting of cyclic moieties, of 5 to 7 atoms in length, and acyclic moieties, of 4 to 6 atoms in length; and, molecules of a reporter, where said reporter is composed of an oligocationic tail adapted to bind electrostatically to the charged backbone of the polynucleotide analyte, and attached to the tail, one or more reporter groups adapted to produce a signal by which the presence of the reporter can be detected.
Claim 3
Dependent Claim 133 words
The system of claim 1, wherein the polymer molecules have the form: ##STR5## where: (a) where R 1 -R n are recognition moieties selected from purine, and pyrimidine heterocycles effective to bind by Watson/Crick pairing to corresponding, contiguous bases in the target sequence, and Bk are backbone moieties; (b) n is such that the total number of Watson/Crick hydrogen bonds formed between a polymer molecule and target sequence is at least 12; (c) the backbone moiety length ranges from 5 to 7 atoms if the backbone moieties have a cyclic structure, and 4 to 6 atoms if the backbone moieties have an acyclic structure; and (d) the backbone moieties support the recognition moieties at positions which allow Watson/Crick base pairing between the recognition moieties and the corresponding, contiguous bases of the target sequences.
Claim 4
Dependent Claim 22 words
The system of claim 2, wherein the recognition moieties are selected from the following group: ##STR6## where X=F, CL, Br, or I.
Claim 5
Dependent Claim 43 words
The system of claim 2, wherein Bk is a cyclic moiety and Bk≈Bk are backbone moieties joined predominantly by chemically stable, uncharged, achiral linkages having one of the following forms: ##STR7## where Y=O, S and ##STR8## and R is a selected recognition moiety.
Claim 6
Dependent Claim 40 words
The system of claim 2, wherein BK is an acyclic moiety and BK˜BK are backbone moieties joined predominantly by chemically stable, uncharged, achiral linkages having one of the following forms: ##STR9## where ##STR10## and R is a selected recognition moiety.
Claim 7
Dependent Claim 34 words
The system of claim 1, wherein the tail in the reporter contains positive groups at intervals whose spacing corresponds approximately to the spacing between adjacent phosphate groups in the backbone of the polynucleotide analyte.
Claim 8
Dependent Claim 29 words
The system of claim 6, wherein the tail contains an oligocationic portion having the formula: ##STR11## where n=2-5, m>0, and each R 1 -R 5 =H or alkyl group.
Claim 9
Dependent Claim 22 words
The system of claim 7, wherein the reporter group in the reporter includes one or more fluorescent, chromophore, enzyme, or radioisotope groups.
Claim 10
Independent Claim 226 words
A method for determination of a polynucleotide analyte containing a selected target base sequence, said method comprising providing a diagnostic reagent composed of a solid support and, attached to the support, multiple polymer molecules, each composed of a heteromeric sequence of base-complementary recognition moieties selected from the group consisting of purine and pyrimidine heterocycles effective to hydrogen-bond to corresponding, contiguous bases in the target sequence, under selected binding conditions, and an unbranched, substantially uncharged, substantially stereoregular backbone, composed of subunit backbone moieties, supporting the recognition moieties at positions which allow hydrogen bonding between the moieties and the corresponding bases in the target sequence, where the subunit backbone moieties are chosen from the group consisting of cyclic moieties, of 5 to 7 atoms in length, and acyclic moieties, of 4 to 6 atoms in length; and, mixing the reagent and an analyte-containing sample under such selected conditions, to produce sequence-specific binding of the analyte to the reagent polymers, providing a reporter composed of an oligocationic tail adapted to bind electrostatically to the charged backbone of the polynucleotide analyte, and attached to the tail, one or more reporter groups adapted to produce a signal by which the presence of the reporter can be detected, binding the reporter to analyte which has bound by sequence-specific binding to the reagent, and determining the extent of reporter binding to the analyte.
Claim 11
Independent Claim 226 words
A method for determination of a polynucleotide analyte containing a selected target base sequence, said method comprising providing a diagnostic reagent composed of a solid support and, attached to the support, multiple polymer molecules, each composed of a heteromeric sequence of base-complementary recognition moieties selected from the group consisting of purine and pyrimidine heterocycles effective to hydrogen-bond to corresponding, contiguous bases in the target sequence, under selected binding conditions, and an unbranched, substantially uncharged, substantially stereoregular backbone, composed of subunit backbone moieties, supporting the recognition moieties at positions which allow hydrogen bonding between the moieties and the corresponding bases in the target sequence, where the subunit backbone moieties are chosen from the group consisting of cyclic moieties, of 5 to 7 atoms in length, and acyclic moieties, of 4 to 6 atoms in length; and, mixing the reagent and an analyte-containing sample under such selected conditions, to produce sequence-specific binding of the analyte to the reagent polymers, providing a reporter composed of an oligocationic tail adapted to bind electrostatically to the charged backbone of the polynucleotide analyte, and attached to the tail, one or more reporter groups adapted to produce a signal by which the presence of the reporter can be detected, binding the reporter to analyte which has bound by sequence-specific binding to the reagent, and determining the extent of reporter binding to the analyte.
Claim 12
Dependent Claim 53 words
The method of claim 9, for use in determination of a duplex nucleic acid analyte, wherein said mixing is performed at a selected ionic strength of less than about 0.2M monovalent cation, in the presence of a divalent cation chelating agent and at a temperature above the melting temperature of such duplex analyte.
Claim 13
Dependent Claim 15 words
The system of claim 1, wherein the backbone of the polymer molecule is substantially stereoregular.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1996-06-07 1996-12-07 1997-06-08 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2000-06-07 2000-12-07 2001-06-08 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2004-06-07 2004-12-07 2005-06-08 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag